TRAX- First Tracks Biotherapeutics, Inc.

Trade Summary

1 week ago, Ware J. Anthony, serving as Dir at First Tracks Biotherapeutics, Inc. (TRAX), sold 39,265 shares at $44.78 per share, for a total transaction value of $1,758,145.35. Following this transaction, Ware J. Anthony now holds 15,660 shares of TRAX.

This sale represents a 71.49% decrease in Ware J. Anthony's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, September 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, September 4, 2026 at 4:25 PM ET, 2 days after the trade was made.

First Tracks Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.